Neurocrine Biosciences
Price & Volume
Stats
See moreOpen | $145.35 |
Previous Close | $146.67 |
Day Range | $141.75-$145.66 |
52W Range | $84.23-$154.61 |
Market Cap | $14.5B |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $2.5B |
Revenue Growth (YoY) | 16.5% |
Gross Profit (12 Mos) | $1.5B |
Diluted EPS | $3.38 |
News
See moreYahoo Finance • 7 hours ago
Should You be Optimistic on Neurocrine Biosciences (NBIX)?
Yahoo Finance • 23 days ago
Neurocrine Biosciences Inc (NASDAQ:NBIX): A Prime GARP Candidate with Strong Growth and Reasonable Valuation
Yahoo Finance • 24 days ago
Neurocrine Biosciences, Inc. (NBIX) Beats Estimates on Neurology Drug Demand, Expands Payer Access
Yahoo Finance • 2 months ago
Guggenheim raises Neurocrine Bio. stock price target on strong Ingrezza sales
About
CEO | Mr. Kyle W. Gano Ph.D. |
Address | 12780 El Camino Real, San Diego, CA, United States, 92130 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 1,800 |
